Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia

DOI Web Site Web Site 被引用文献10件

抄録

<jats:title>Summary</jats:title><jats:p><jats:bold>Background</jats:bold> : An effective therapeutic strategy for functional dyspepsia (FD) has not been well‐established.</jats:p><jats:p><jats:bold>Aim</jats:bold> : We investigated and compared the therapeutic effects of famotidine, mosapride and tandospirone for the control of dyspeptic symptoms.</jats:p><jats:p><jats:bold>Methods</jats:bold> : Fully examined FD patients of outpatient clinics at seven different medical centres were enrolled in the study. They were randomly assigned to three groups based on the type of drug administered: famotidine, mosapride and tandospirone. The effects of treatment over 4 weeks were assessed by visual analogue scales.</jats:p><jats:p><jats:bold>Results</jats:bold> : All of the drugs showed beneficial effects, although famotidine was the most effective for symptom relief, which was significantly greater than tandospirone, while the effect of mosapride was similar to that of famotidine. No subtype of FD showed a better response to a particular type of drug.</jats:p><jats:p><jats:bold>Conclusions</jats:bold> : For the treatment of FD, famotidine demonstrated the best therapeutic effect, followed by mosapride, while that of tandospirone was significantly lower.</jats:p>

収録刊行物

被引用文献 (10)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ